37th ACS National Medicinal Chemistry Symposium

American Chemical Society
Division of Medicinal Chemistry

 New York City, NY, United States    June 26-29, 2022

Session Topics & Chairs

The Program of the 37th NMCS will include the following Sessions:

  • Integrating Novel Chemical Modalities in Hit-to-lead: a New Paradigm for Early Drug Discovery
    Chair: Maria-Jesus Blanco (Atavistik Bio)

  • New Directions in Targeting DNA Damage Repair (DDR)
    Chairs: Erin DiMauro (Merck & Co. Inc.) and Srinivasa Karra (Avilar Therapeutics)

  • Hot Targets from NYC Academic and Biotech Scene
    Chairs: Robert DeVita (Icahn School of Medicine at Mt Sinai) and Amjad Ali (Merck & Co. Inc.)

  • Targeting Autophagy for Cancer, Neurodegeneration, or Autoimmune Disease
    Chairs: Erin DiMauro (Merck & Co. Inc.) and Hongjun Zhang (Cerevel Therapeutics, LLC.)

  • Next Generation Therapies Shaped by Clinical Data
    Chair: Matthew Volgraf (Septerna)

  • Lessons from Drug Hunters across Academia, NPOs and the Pharmaceutical Industry
    Chair: Phil Kym (AbbVie)

In addition, the Program will also feature an Award Session.